Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;21(6):2113-2122.
doi: 10.1111/ajt.16388. Epub 2020 Nov 20.

Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study

Affiliations

Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study

Emily M Eichenberger et al. Am J Transplant. 2021 Jun.

Abstract

We undertook a prospective, matched cohort study of patients with Staphylococcus aureus bacteremia (SAB) and gram-negative bacteremia (GNB) to compare the characteristics, outcomes, and chemokine and cytokine response in transplant recipients to immunocompetent, nontransplant recipients. Fifty-five transplant recipients (GNB n = 29; SAB n = 26) and 225 nontransplant recipients (GNB n = 114; SAB n = 111) were included for clinical analysis. Transplant GNB had a significantly lower incidence of septic shock than nontransplant GNB (10.3% vs 30.7%, p = .03). Thirty-day mortality did not differ significantly between transplant and nontransplant recipients with GNB (10.3% vs 15.8%, p = .57) or SAB (0.0% vs 11.7%, p = .13). Next, transplant patients were matched 1:1 with nontransplant patients for the chemokine and cytokine analysis. Five cytokines and chemokines were significantly lower in transplant GNB vs nontransplant GNB: IL-2 (median [IQR]: 7.1 pg/ml [7.1, 7.1] vs 32.6 pg/ml [7.1, 88.0]; p = .001), MIP-1β (30.7 pg/ml [30.7, 30.7] vs 243.3 pg/ml [30.7, 344.4]; p = .001), IL-8 (32.0 pg/ml [5.6, 53.1] vs 59.1 pg/ml [39.2, 119.4]; p = .003), IL-15 (12.0 pg/ml [12.0, 12.0] vs 12.0 pg/ml [12.0, 126.7]; p = .03), and IFN-α (5.1 pg/mL [5.1, 5.1] vs 5.1 pg/ml [5.1, 26.3]; p = .04). Regulated upon Activation, Normal T Cell Expressed and Secreted (RANTES) was higher in transplant SAB vs nontransplant SAB (mean [SD]: 750.2 pg/ml [194.6] vs 656.5 pg/ml [147.6]; p = .046).

Keywords: clinical research/practice; cytokines/cytokine receptors; immunosuppression/immune modulation; infection and infectious agents - bacterial; infectious disease; organ transplantation in general; translational research/science.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURES

The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. VGF reports personal fees from Novartis, Novadigm, Durata, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., Cerexa, Tetraphase, Trius, MedImmune, Bayer, Theravance, Basilea, Affinergy, Janssen, xBiotech, Contrafect, Regeneron, Basilea, Destiny, Amphliphi Biosciences. Integrated Biotherapeutics; C3J, grants from NIH, MedImmune, Cerexa/Forest/Actavis/Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Cubist/Merck; Medical Biosurfaces; Locus; Affinergy; Contrafect; Karius; Genentech, Regeneron, Basilea, Janssen, from Green Cross, Cubist, Cerexa, Durata, Theravance; Debiopharm, Royalties from UpToDate; and a patent sepsis diagnostics pending.

Figures

Figure 1:
Figure 1:. Study design
Clinical analysis was performed on the 55 transplant cases and 227 eligible controls (Boxes B and C). Corresponding tables for this comparison are tables 1–3. Chemokine and cytokine analysis was performed on the 55 transplant cases and 60 matched controls (Boxes B and D). Corresponding tables for this comparison are tables 4–5. SAB, S. aureus bacteremia; GNB, gram-negative bacteremia
Figure 2A-F:
Figure 2A-F:. Cytokine and chemokine levels differ by transplant status in patients with gram-negative bacteremia and S. aureus bacteremia.
GNB, gram-negative bacteremia; SAB, S. aureus bacteremia; ns, not significant. Box plot extends from 25th to 75th percentile. The line in middle of box denotes median. Whiskers extend to 10th and 90th percentile. P-values were determined using Wilcoxon Rank Sum tests. Analyte concentrations below the lower limit of quantitation were replaced with one-half of the lower limit of quantitation. Thus when multiple patients had cytokine levels below the limit of detection, the 1st and 3rd quartiles were identical to the median.

Similar articles

Cited by

References

    1. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357(25):2601–2614. - PubMed
    1. Kalil AC, Dakroub H, Freifeld AG. Sepsis and solid organ transplantation. Curr Drug Targets. 2007;8(4):533–541. - PubMed
    1. Guenette A, Husain S. Infectious Complications Following Solid Organ Transplantation. Crit Care Clin. 2019;35(1):151–168. - PMC - PubMed
    1. Abe R, Oda S, Sadahiro T, et al. Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care. 2010;14(2):R27. - PMC - PubMed
    1. Rose WE, Eickhoff JC, Shukla SK, et al. Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis. 2012;206(10):1604–1611. - PMC - PubMed

Publication types